![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 6
2018
Unterrainer, M.; Winkelmann, I.; Suchorska, B.; Giese, A.; Wenter, V.; Kreth, F. W.; Herms, J.; Bartenstein, P.; Tonn, J. C. und Albert, Nathalie L. 
ORCID: https://orcid.org/0000-0003-0953-7624
(2018):
Biological tumour volumes of gliomas in early and standard 20-40 min F-18-FET PET images differ according to IDH mutation status.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 7: S. 1242-1249
ORCID: https://orcid.org/0000-0003-0953-7624
(2018):
Biological tumour volumes of gliomas in early and standard 20-40 min F-18-FET PET images differ according to IDH mutation status.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 45, Nr. 7: S. 1242-1249
2017
Vettermann, F. J.; Neumann, J. E.; Suchorska, B.; Bartenstein, P.; Giese, A.; Dorostkar, M. M.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624 und Schüller, U.
(2017):
K27M midline gliomas display malignant progression by imaging and histology.
In: Neuropathology and Applied Neurobiology, Bd. 43, Nr. 5: S. 458-462
ORCID: https://orcid.org/0000-0003-0953-7624 und Schüller, U.
(2017):
K27M midline gliomas display malignant progression by imaging and histology.
In: Neuropathology and Applied Neurobiology, Bd. 43, Nr. 5: S. 458-462
Biczok, A.; Kraus, T.; Suchorska, B.; Terpolilli, N.; Tonn, J. und Schichor, C.
(2017):
Prognostic Value of Tert Promoter Mutation in Aggressive Meningiomas.
In: Neuro-Oncology, Bd. 19: S. 95
2016
Suchorska, B.; Biczok, A.; Lenski, M.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Schüller, U. und Tonn, J.
(2016):
Prognostic value of contrast enhancement and histopathological grading in diffuse gliomas depends on IDH1/2 mutation.
In: Neuro-Oncology, Bd. 18: S. 37
ORCID: https://orcid.org/0000-0003-0953-7624; Schüller, U. und Tonn, J.
(2016):
Prognostic value of contrast enhancement and histopathological grading in diffuse gliomas depends on IDH1/2 mutation.
In: Neuro-Oncology, Bd. 18: S. 37
Suchorska, B.; Hamisch, C.; Treuer, H.; Mahnkopf, K.; Lehrke, R. E.; Kocher, M.; Ruge, M. I. und Voges, J.
(2016):
Stereotactic brachytherapy using iodine 125 seeds for the treatment of primary and recurrent anaplastic glioma WHO° III.
In: Journal of Neuro-Oncology, Bd. 130, Nr. 1: S. 123-131
Vomacka, L.; Albert, Nathalie L. ORCID: https://orcid.org/0000-0003-0953-7624; Mille, E.; Suchorska, B.; Unterrainer, M.; Gosewisch, A.; Bartenstein, P. und Boening, G.
(2016):
3D analysis of glioma heterogeneity with pseudo-kinetic and pharmacokinetic model parameters in dynamic 18F-FET PET.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43:
S194-S194
ORCID: https://orcid.org/0000-0003-0953-7624; Mille, E.; Suchorska, B.; Unterrainer, M.; Gosewisch, A.; Bartenstein, P. und Boening, G.
(2016):
3D analysis of glioma heterogeneity with pseudo-kinetic and pharmacokinetic model parameters in dynamic 18F-FET PET.
In: European Journal of Nuclear Medicine and Molecular Imaging, Bd. 43:
S194-S194